Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.
MEDPSector12 quartersMarket cap$18.26B$9.67BEnterprise value—$10.41BAvg daily $ volume$180.16M$132.68MDaily turnover1.0%1.3%
MEDPSector12 quartersRevenue CAGR 3y18.5%9.5%Revenue CAGR 5y22.0%8.9%Revenue growth YoY17.2%8.7%Revenue acceleration−9.3 pp+0.0 ppFCF growth YoY21.9%5.9%FCF conversion143.8%130.8%Forward growth (HoM est.)17.9%9.8% MEDPSector12 quartersP/E (trailing)37.1×27.6×P/E (forward, HoM est.)31.5×25.2×P/E vs. sector1.4×1.0×PEG (HoM est.)1.763.12EV/EBITDA—17.5×EV/Sales—3.3×FCF yield—3.6%Dividend yield0.0%0.0%Shareholder yield1.6%1.2%
MEDPSector12 quartersQuality checks passed43ROIC—9.2%Gross profitability—32.6%Gross margin—60.1%Gross margin Δ 3y—−0.1 ppOperating margin21.0%10.6%Operating margin Δ 3y+1.9 pp+0.9 ppDebt/equity—0.7×Net debt/EBITDA—2.0×Interest coverage—4.9×Share count Δ 3y-8.7%-0.3%Stock compensation / revenue0.8%1.8%Accruals ratio-14.4%-4.3% MEDPSector12 quartersDays to next report013
MEDPSector12 quartersInsider buys (90d)00Insiders buying (90d)00Insider net value (90d)-$178.15M$0Institutional ownership88.4%99.6%Institutional Δ QoQ+3.1 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying+5.9 pp+0.1 ppActive funds net buying+0.0 pp+0.0 ppDays to cover5.804.29Short % of shares out5.7%6.0%Short interest Δ−0.3 pp+0.1 pp